Solventum Corp (SOLV) stock
SOLVNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3092% above fair value
$88.81+0.19 (+0.21%)
Close on Nov 12, 2026Market cap $15.12BP/E 99.8Yield –
Solventum operating margin
Operating margin is operating income as a percentage of revenue.
Solventum's operating margin for the twelve months ending Sep 30, 2026 was 5.6%. For fiscal 2025 it was 26.2%, against 12.6% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 26.2% | +13.6 |
| FY2024 | Dec 31, 2024 | 12.6% | −8.1 |
| FY2023 | Dec 31, 2023 | 20.6% | −0.2 |
| FY2022 | Dec 31, 2022 | 20.8% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 3.5% | −77.1 |
| Q2 FY2026 | Jun 30, 2026 | 8.2% | −1.7 |
| Q1 FY2026 | Mar 31, 2026 | 4.0% | −3.3 |
| Q4 FY2025 | Dec 31, 2025 | 6.2% | −0.3 |
| Q3 FY2025 | Sep 30, 2025 | 80.6% | +67.4 |
| Q2 FY2025 | Jun 30, 2025 | 9.9% | −1.8 |
| Q1 FY2025 | Mar 31, 2025 | 7.3% | −11.6 |
| Q4 FY2024 | Dec 31, 2024 | 6.6% | −13.4 |
| Q3 FY2024 | Sep 30, 2024 | 13.2% | −11.1 |
| Q2 FY2024 | Jun 30, 2024 | 11.7% | −8.4 |
| Q1 FY2024 | Mar 31, 2024 | 18.9% | +0.7 |
| Q4 FY2023 | Dec 31, 2023 | 19.9% | – |
| Q3 FY2023 | Sep 30, 2023 | 24.3% | – |
| Q2 FY2023 | Jun 30, 2023 | 20.1% | – |
| Q1 FY2023 | Mar 31, 2023 | 18.2% | – |
See a number that looks wrong?